Prior to MAPT being identified in genetic association studies as a risk locus for PD, PSP and CBD, the tau protein was already of interest in a number of neurodegenerative disorders due to the presence of abnormally phosphorylated tau protein in pathological aggregations in the form of neurofibrillary tangles. This evidence concerns the gene MAPT and red-green color blindness.